| Announce Date | 10/08/2025 | 
| EPS Normalized Actual | $0.09 In Line | 
| EPS GAAP Actual | $0.09 In Line | 
| Revenue Actual | $0.080103B | 
| Revenue Surprise | Beat by $80.103M | 
| Announce Date | 12/01/2025 (Pre-Market) | 
| EPS Normalized Estimate | $0.61 | 
| EPS GAAP Estimate | $0.61 | 
| Revenue Estimate | $0.106924B | 
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| Nov 2027 | 1.39 | 10.58 | 1.2 | 1.58 | 2 | 
| Nov 2026 | 1.2 | 12.26 | 1.19674 | 1.20326 | 1 | 
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss | 
|---|---|---|---|---|---|
| FQ3 2025 (Aug 2025) | 0.0926 | -0.0724 | 0.080103B | 5.6% | -4.14M | 
| FQ2 2025 (May 2025) | 0.22 | 0.22 | 0.084348B | 1.11% | 84.35M | 
| FQ1 2025 (Mar 2025) | 0.21 | 0.21 | 0.04683B | -84.83% | 46.83M | 
| FQ4 2024 (Nov 2024) | 0.37 | 0.37 | 0.047695B | 100% | 47.7M | 
| FQ3 2024 (Aug 2024) | -0.51 | -0.51 | 0.075619B | -15.34% | 75.62M | 
| FQ2 2024 (Jun 2024) | -0.82 | -0.82 | 0.08341B | 100% | 83.41M | 
| FQ1 2024 (Mar 2024) | -0.14 | -0.14 | 0.086554B | -24.43% | 86.55M | 
| FQ3 2023 (Aug 2023) | -0.3 | -0.3 | 0.087217B | 100% | 87.22M | 
FQ4 Announce Date
12/01/2025 (Pre-Market)
Consensus EPS Estimates
0.61
Consensus Revenue Estimates
0.106924B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.54 | -- | 0.53759 | 0.54237 | 1 | 
| FQ3 2026 (Aug 2026) | 0.42 | 77.95 | 0.42 | 0.42 | 1 | 
| FQ2 2026 (May 2026) | 0.32 | 31.25 | 0.32 | 0.32 | 1 | 
| FQ1 2026 (Feb 2026) | 0.35 | 40 | 0.35 | 0.35 | 1 | 
| FQ4 2025 (Dec 2025) | 0.61 | 39.34 | 0.60364 | 0.61641 | 0 | 
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.07B | -- | 0.07B | 0.07B | 1 | 
| FQ3 2026 (Aug 2026) | 0.04B | -109.82 | 0.04B | 0.04B | 1 | 
| FQ2 2026 (May 2026) | 0.04B | -114.02 | 0.04B | 0.04B | 1 | 
| FQ1 2026 (Feb 2026) | 0.05B | -0.83 | 0.05B | 0.05B | 1 | 
| FQ4 2025 (Dec 2025) | 0.11B | 55.39 | 0.11B | 0.11B | 0 | 
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
EPS # of Beats
3
EPS # of Misses
5
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ3 2025 (Aug 2025) | 0.165 | 0.0926 | -0.0724 | -78.19% | 
| FQ2 2025 (May 2025) | 0.22 | 0.22 | 100% | |
| FQ1 2025 (Mar 2025) | 0.21 | 0.21 | 100% | |
| FQ4 2024 (Nov 2024) | 0.37 | 0.37 | 100% | |
| FQ3 2024 (Aug 2024) | -0.51 | -0.51 | 100% | |
| FQ2 2024 (Jun 2024) | -0.82 | -0.82 | 100% | |
| FQ1 2024 (Mar 2024) | -0.14 | -0.14 | 100% | |
| FQ3 2023 (Aug 2023) | -0.3 | -0.3 | 100% | 
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ3 2025 (Aug 2025) | $0.08B | $0.08B | $-4.14M | -5.16% | 
| FQ2 2025 (May 2025) | $0B | $0.08B | $84.35M | 100% | 
| FQ1 2025 (Mar 2025) | $0B | $0.05B | $46.83M | 100% | 
| FQ4 2024 (Nov 2024) | $0B | $0.05B | $47.7M | 100% | 
| FQ3 2024 (Aug 2024) | $0B | $0.08B | $75.62M | 100% | 
| FQ2 2024 (Jun 2024) | $0B | $0.08B | $83.41M | 100% | 
| FQ1 2024 (Mar 2024) | $0B | $0.09B | $86.55M | 100% | 
| FQ3 2023 (Aug 2023) | $0B | $0.09B | $87.22M | 100% |